Gennaio 2011 - Volume XXX - numero 1
Linee guida
S. Cesaro1, S. Bezzio2, M. Giacchino2, A. Barone3, L. Battisti4, D. Caselli5, R. De Santis6, F. Fioredda7, S. Frenos5,
S. Livadiotti8, S. Marinello9, G.A. Zanazzo10
1SC Onco-Ematologia Pediatrica, Azienda Ospedaliero-Universitaria Integrata, Verona
2SC Onco-Ematologia Pediatrica, Azienda Ospedaliera OIRM - S. Anna, Torino
3SC Pediatria e Oncoematologia, Azienda Ospedaliera di Parma
4Dipartimento di Pediatria, Ospedale di Bolzano
5SC Onco-Ematologia Pediatrica, Ospedale Meyer, Firenze
6SC Onco-Ematologia Pediatrica, Ospedale “Casa Sollievo della Sofferenza”, S. Giovanni Rotondo (Foggia)
7Ematologia Pediatrica, Istituto “G. Gaslini”, Genova
8Immunologia Pediatrica e Malattie Infettive, Ospedale Bambino Gesù, Roma
9Divisione di Malattie Infettive, Azienda Ospedaliera di Padova
10SC Onco-Ematologia Pediatrica, IRCCS “Burlo Garofolo”, Trieste
Indirizzo per corrispondenza: zanazzo@burlo.trieste.it
Key words: Vaccination, Chemotherapy, Paediatric cancer, Guidelines
Aim - Defining the guidelines on vaccinations in paediatric cancer patients. Method - We reviewed the literature published from 1980 to 2009 according to the methodology suggested by the American Society of Infectious Disease. The intention was to define recommendations on vaccinations in patients both during and after chemotherapy as well as recommendation on vaccinations in family members. The conclusions achieved were presented in 2 plenary discussion sessions before final approval. In case of disagreement the issue was settled by discussion with an external expert. Results - While on chemotherapy, the patient benefits HBV and influenza vaccinations. During this phase, family members are advised to continue vaccinations as scheduled by health plan or, if seronegative, vaccinations against varicella, measles, mumps, rubeola are recommended. Although a reduction of serum antibody levels for vaccine-preventable disease is reported following suspension of chemotherapy, the immunological memory seems preserved. The response to booster is generally good, gives the patients good protection and contributes to herd immunity.
Vuoi citare questo contributo?